Aurobindo Pharma Share Price in Focus; Subsidiary Apitoria Incorporates Avogent Lifesciences

Aurobindo Pharma Limited has incorporated a new subsidiary through Apitoria Pharma Private Limited, which is already a wholly owned subsidiary of the company. The new entity, Avogent Lifesciences Private Limited, was incorporated in India on August 31, 2026. 

Aurobindo Pharma informed about the development on September 1, 2026, under Regulation 30 of the SEBI Listing Regulations.  

Initial Capital at ₹5 Crore 

An initial capital of ₹5 crore was subscribed for Avogent Lifesciences, comprising 50 lakh equity shares with a face value of ₹10 apiece. 

Apitoria Pharma has subscribed to the entire share capital in cash and holds 100% ownership of the new company.  

Business Activities 

Operating in the pharmaceutical sector, Avogent Lifesciences has been set up to carry out manufacturing and marketing activities in India and abroad. The filing contains no further details on the specific products it intends to handle. It also states that no government or regulatory approvals were required for the incorporation.  

No Turnover History 

Since Avogent Lifesciences has only recently been incorporated, turnover details are not applicable. The company also does not have a financial or operating record for the previous three years. 

The new entity is considered a related party of Aurobindo Pharma because it is held through Apitoria Pharma. The company said its promoters and promoter group have no interest in the transaction.  

Read More: ONGC Share Price in Focus; Plans to Invest ₹1 Lakh Crore for Deepwater Exploration with 87 Wells Over 5 Years! 

Aurobindo Pharma Share Price Performance  

As of September 1, 2026, 12:36 pm, Aurobindo Pharma share price was trading at ₹1,694.00, a 1.34% decrease from the previous closing price. 

Conclusion 

Avogent Lifesciences is a newly incorporated company under Aurobindo Pharma’s existing subsidiary structure. It begins with ₹5 crore in subscribed capital and has been set up for pharmaceutical manufacturing and marketing activities in India and overseas. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.